Ozempic is the primary topic on Retapedia for the
terms listed below. This page distinguishes other meanings and
related entries.
Ozempic (also called Semaglutide, GLP-1 agonist, Ozempic, Wegovy, Rybelsus) may refer to:
Primary topic
- Ozempic — Reduces appetite and slows digestion for 15-21% weight loss. Improves blood sugar control. Lowers heart attack and stroke risk by 20%.
Also known as
The following names are catalogued aliases for the primary topic:
- Semaglutide
- GLP-1 agonist
- Ozempic
- Wegovy
- Rybelsus
Related entries on Retapedia
- GLP-1 receptor agonist — A class of peptide drugs that mimic glucagon-like peptide-1 to enhance insulin secretion, slow gastric emptying, and reduce appetite. Approved for type-2 diabetes and obesity.
External meanings
The term Semaglutide may carry meanings outside this catalogue — for example, as a developmental code shared with an unrelated chemical entity, or as a trademarked product name in a different therapeutic area. Retapedia does not catalogue non-peptide compounds; consult an external reference such as PubChem or Wikidata for broader coverage.
Categories:
Disambiguation pages